Thus, given the high expression of CSPG4 on melanoma cells, we sought to use this established tumor antigen to test whether engineering macrophages to target an antigen on melanoma cells will lead to high macrophage infiltration into melanoma tumors and robust melanoma phagocytosis and clearance. The gene discussed is CSPG4; the disease is melanoma.